Insulin Receptor Substrate Proteins
"Insulin Receptor Substrate Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share an N-terminal PLECKSTRIN HOMOLOGY DOMAIN, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation, insulin receptor substrate proteins interact with specific SH2 DOMAIN containing proteins that are involved in insulin receptor signaling.
Descriptor ID |
D055504
|
MeSH Number(s) |
D12.644.360.024.301 D12.776.157.057.045 D12.776.476.024.382
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Receptor Substrate Proteins".
Below are MeSH descriptors whose meaning is more specific than "Insulin Receptor Substrate Proteins".
This graph shows the total number of publications written about "Insulin Receptor Substrate Proteins" by people in this website by year, and whether "Insulin Receptor Substrate Proteins" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 3 | 3 |
1996 | 0 | 5 | 5 |
1997 | 0 | 1 | 1 |
1998 | 0 | 5 | 5 |
1999 | 0 | 2 | 2 |
2000 | 0 | 5 | 5 |
2001 | 0 | 7 | 7 |
2002 | 0 | 10 | 10 |
2003 | 0 | 7 | 7 |
2004 | 0 | 8 | 8 |
2005 | 0 | 11 | 11 |
2006 | 0 | 6 | 6 |
2007 | 0 | 1 | 1 |
2008 | 1 | 4 | 5 |
2009 | 2 | 2 | 4 |
2010 | 3 | 4 | 7 |
2011 | 2 | 4 | 6 |
2012 | 1 | 4 | 5 |
2013 | 2 | 2 | 4 |
2014 | 6 | 2 | 8 |
2015 | 1 | 4 | 5 |
2016 | 2 | 2 | 4 |
2017 | 1 | 2 | 3 |
2019 | 2 | 0 | 2 |
2020 | 1 | 1 | 2 |
2021 | 1 | 1 | 2 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Insulin Receptor Substrate Proteins" by people in Profiles.
-
Associations of renin-angiotensin system inhibitor use with brain insulin signaling and neuropathology. Ann Clin Transl Neurol. 2024 Aug; 11(8):2112-2122.
-
Arsenic disrupts neuronal insulin signaling through increasing free PI3K-p85 and decreasing PI3K activity. Toxicol Lett. 2021 Oct 01; 349:40-50.
-
Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nat Commun. 2021 01 05; 12(1):24.
-
Adiponectin GWAS loci harboring extensive allelic heterogeneity exhibit distinct molecular consequences. PLoS Genet. 2020 09; 16(9):e1009019.
-
Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. JCI Insight. 2020 03 26; 5(6).
-
Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway. Diabetologia. 2020 03; 63(3):577-587.
-
Acute Insulin Resistance and Rapid Alterations in Neuronal Derived Blood Exosome Concentration After Branched Endovascular Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2020 Mar; 59(3):457-463.
-
Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study. Hum Mol Genet. 2019 08 15; 28(16):2659-2674.
-
Commutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs. J Mol Cell Biol. 2019 06 01; 11(6):509-520.
-
Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells. Endocrinology. 2018 01 01; 159(1):285-296.